Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Proceedings of the National Academy of Sciences · 15.10.2024 · 121 (42)
DOI: 10.1073/pnas.2409166121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.10.2024. Verfasst von Eric M Merten und 28 weiteren Autor:innen. Beteiligte Einrichtung: Eshelman School of Pharmacy, Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Univer…. Hauptthemen laut MEDLINE: Chikungunya virus, Cysteine Endopeptidases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Cancer Institute (NCI), NCI NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that has been responsible for numerous large-scale outbreaks in the last twenty years. Currently, there are no FDA-approved therapeutics for any alphavirus infection. CHIKV nonstructural protein 2 (nsP2), which contains a cysteine protease domain, is essential for viral replication, making it an attractive target for a drug discovery campaign. Here, we optimized a CHIKV nsP2 protease (nsP2pro) biochemical assay for the screening of a 6,120-compound cysteine-directed covalent fragment library. Using a 50% inhibition threshold, we identified 153 hits (2.5% hit rate). In dose–response follow-up, RA-0002034, a covalent fragment that contains a vinyl sulfone warhead, inhibited CHIKV nsP2pro with an IC 50 of 58 ± 17 nM, and further analysis with time-dependent inhibition studies yielded a k inact /K I of 6.4 × 10 3 M −1 s −1 . LC-MS/MS analysis determined that RA-0002034 covalently modified the catalytic cysteine in a site-specific manner. Additionally, RA-0002034 showed no significant off-target reactivity in proteomic experiments or against a panel of cysteine proteases. In addition to the potent biochemical inhibition of CHIKV nsP2pro activity and exceptional selectivity, RA-0002034 was tested in cellular models of alphavirus infection and effectively inhibited viral replication of both CHIKV and related alphaviruses. This study highlights the identification and characterization of the chemical probe RA-0002034 as a promising hit compound from covalent fragment-based screening for development toward a CHIKV or pan-alphavirus therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eshelman School of Pharmacy, Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- Proteomics Core Facility, Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
- Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006.
- Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
ORCID-Profile: Eric M Merten, John D Sears, Tina M Leisner, Anirban Ghoshal, Mohammad Anwar Hossain, Kesatebrhan Haile Asressu, Peter J Brown, Edwin G Tse, Kelin Li, Jacqueline L Norris-Drouin, Laura E Herring, Angie L Mordant, Sumera Perveen, Mark T Heise, Timothy M Willson, Kenneth H Pearce
Förderung
- HHS | NIH | National Cancer Institute (NCI)
- NCI NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- NIH HHS
- NIAID NIH HHS
Zitieren
APA
Merten, E. M., Sears, J. D., Leisner, T. M., Hardy, P. B., Ghoshal, A., Hossain, M. A., Asressu, K. H., Brown, P. J., Tse, E. G., Stashko, M. A., Li, K., Norris-Drouin, J. L., Herring, L. E., Mordant, A. L., Webb, T. S., Mills, C. A., Barker, N. K., Streblow, Z. J., Perveen, S., …, & Pearce, K. H. (2024). Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach. Proceedings of the National Academy of Sciences, 121(42). https://doi.org/10.1073/pnas.2409166121
Vancouver
Merten EM, Sears JD, Leisner TM, Hardy PB, Ghoshal A, Hossain MA, et al. Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach. Proceedings of the National Academy of Sciences. 2024;121(42). doi:10.1073/pnas.2409166121
BibTeX
@article{Merten2024,
author = {Merten, Eric M and Sears, John D and Leisner, Tina M and Hardy, P Brian and Ghoshal, Anirban and Hossain, Mohammad Anwar and Asressu, Kesatebrhan Haile and Brown, Peter J and Tse, Edwin G and Stashko, Michael A and Li, Kelin and Norris-Drouin, Jacqueline L and Herring, Laura E and Mordant, Angie L and Webb, Thomas S and Mills, Christine A and Barker, Natalie K and Streblow, Zachary J and Perveen, Sumera and Arrowsmith, Cheryl H and Couñago, Rafael Miguez and Arnold, Jamie J and Cameron, Craig E and Streblow, Daniel N and Moorman, Nathaniel J and Heise, Mark T and Willson, Timothy M and Popov, Konstantin I and Pearce, Kenneth H},
title = {Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {42},
doi = {10.1073/pnas.2409166121}
}
EUVIMED